Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

CAMBRIDGE, England, February 20 /PRNewswire/ --

- ARM Expands its Graphics Stack With Mali-JSR297 Software for Graphics Acceleration on a Wide Range of Next-Generation Mobile Devices

OXFORD, England, February 20 /PRNewswire/ -- t+ Medical, the UK's leading supplier of telemedicine solutions for long term conditions has partnered with LifeScan, Inc, a leading manufacturer of blood glucose meters to help people with diabetes more effectively manage their condition.

t+ Medical provides a comprehensive system of care which takes data from LifeScan blood glucose meters and wirelessly transmits the information to a central database. Using intelligent algorithms; this information is then analyzed and translated for patients in the form of simple graphs which can be viewed on their mobile phone or a personal computer. Patients are therefore able to track their condition, and monitor their diabetes giving them greater insight into their disease day by day.

WORCESTER, England, February 20 /PRNewswire/ -- In the current economic climate, every retailer is looking for ways to improve efficiency and maintain profitability by grabbing a larger share of the market. Many major corporations are already using weather forecasts to aid in their business strategies, but smaller retailers may be ignoring a key to continued success in a challenging period.

It is estimated that some 10% of the British economy is weather sensitive, with billions of pounds of revenue being lost every year due to retailers not having or acting upon the correct weather information.

LONDON, February 20 /PRNewswire/ -- Manpower Software plc, the leading provider of workforce optimization and scheduling solutions, and Affiliated Computer Services, Inc. (ACS), a global provider of business process outsourcing, information technology, and consulting solutions, today announced a strategic partnership to deliver Manpower Software's market-leading MAPS Health Suite, a workforce optimization and scheduling solution, to the U.S. healthcare market. Under the agreement, ACS Healthcare Solutions (ACS HCS) will also serve as Manpower Software's systems integrator in the United States.

Manpower Software plc CEO, Ian Bowles, commented:

AMSTERDAM, February 20 /PRNewswire/ --

- Conference Call & Webcast Today at 10:00 CET

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its full year 2007 results.

Highlights

- Successful IPO, raising gross proceeds of EUR 55.7 million

- Cash & cash equivalents of EUR 51.3 million at June 30, 2007

- U.S. FDA orphan drug designation for lead product AMT 011

- Positive results of Phase I/II in LPL type I deficiency

- Pre-registration trial in Canada on track

- Appointment of Ferdinand Verdonck as chairman of supervisory board.

- Global rights for acute intermittent porphyria treatment

- Exclusive license to all gene therapy products from CIMA

PHILADELPHIA and LONDON, February 20 /PRNewswire/ --

- Survey Takes a Look at Who Had the Highest Impact in Molecular Biology and Genetics 2002-2006

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the results of a study assessing high-impact research in molecular biology and genetics. In the January/February issue of Science Watch, Thomson Scientific analyzes data from its Essential Science Indicators to identify molecular biology and genetics papers that rank among the top one percent most cited in the field for their respective years of publication between 2002 and 2006.